The Journal of Urology
Volume 176, Issue 4 , Pages 1654-1660, October 2006

Contrast Enhanced Ultrasound for Radio Frequency Ablation of Canine Prostates: Initial Results

  • Ji-Bin Liu

      Affiliations

    • Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
    • Corresponding Author InformationCorrespondence: Department of Radiology, 7th Floor, Main Building, 132 South 10th St., Thomas Jefferson University Hospital, Philadelphia, Pennsylvania 19107 (telephone: 215-955-4862; FAX: 215-955-8549)
  • ,
  • Daniel A. Merton

      Affiliations

    • Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
  • ,
  • Gervais Wansaicheong

      Affiliations

    • Department of Diagnostic Radiology, Tan Tock Seng Hospital, Singapore
  • ,
  • Flemming Forsberg

      Affiliations

    • Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
  • ,
  • Pamela R. Edmonds

      Affiliations

    • Department of Pathology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
  • ,
  • Xue-Dong Deng

      Affiliations

    • Department of Ultrasound, Nanjing Medical University Suzhou Hospital, Chengdu, People’s Republic of China
  • ,
  • Yan Luo

      Affiliations

    • Suzhou and Sichuan University Huaxi Hospital, Chengdu, People’s Republic of China
  • ,
  • Laurence Needleman

      Affiliations

    • Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
  • ,
  • Ethan Halpern

      Affiliations

    • Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania
  • ,
  • Barry B. Goldberg

      Affiliations

    • Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania

Received 1 September 2005

Purpose

We determined the feasibility of contrast enhanced ultrasound for radio frequency ablation of the entire prostate as a method of minimally invasive treatment for prostate cancer in a canine model.

Materials and Methods

Approval of the Institutional Animal Use and Care committee was obtained. Initially 5 dogs (group 1) were tested using variable power (5 to 30 W), time (4 to 12 minutes), bolus (0.01 to 0.04 ml/kg) and infusion (3 to 11 ml per minute at 0.015 μl/kg) injections of an ultrasound contrast agent with conventional grayscale power Doppler and pulse inversion harmonic imaging to establish optimal parameters. Subsequently 4 dogs (group 2) underwent entire prostate ablation using parameters based on group 1. The size of the thermal lesions and residual viable tissue was measured with ImageJ software (National Institutes of Health, Bethesda, Maryland) on ultrasound and pathological study. Linear regression and Student’s t test were used for statistical analysis.

Results

A bolus of 0.04 ml/kg, an infusion of 11 ml per minute at 0.015 μl/kg and the contrast enhanced pulse inversion harmonic imaging mode were ranked best for guiding ablation. Thermal lesion volume was proportional to ablation power and time. There was no significant difference in measured thermal lesion size in group 1 between ultrasound and pathological findings (mean ± SD 1.51 ± 0.74 and 1.46 ± 0.74 cm3, p = 0.56) or in residual viable tissue in group 2 (0.43 ± 0.043 and 0.41 ± 0.291 cm3, p = 0.21). The average volume of prostate ablation achieved in group 2 was 96.3%.

Conclusions

Contrast enhanced pulse inversion harmonic imaging is able to guide, monitor and control radio frequency ablation of the entire prostate.

Key Words:  ablation , ultrasonography , prostate , contrast media , neoplasms

Abbreviations and Acronyms:  PIHI, pulse inversion harmonic imaging , RF, radio frequency , TTC, triphenyl tetrazolium chloride , US, ultrasound

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 Study received Institutional Animal Use and Care committee approval.Supported by National Institutes of Health Grant EB002794.

PII: S0022-5347(06)01531-X

doi:10.1016/j.juro.2006.06.090

The Journal of Urology
Volume 176, Issue 4 , Pages 1654-1660, October 2006